Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check4 days agoChange DetectedThe study page now shows a 403 Forbidden error page instead of the study content. The new additions include the 403 header and basic HTML structure, indicating access is blocked, while the detailed study information previously on the page is no longer accessible.SummaryDifference20%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision changed from v3.6.5 to v3.6.6, indicating a new version of the study page was published. This appears to be a routine maintenance update to the page metadata rather than substantive content changes.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows a server error indicating the page is unavailable, and the detailed study content has been removed, leaving an inaccessible study record for NCT03631407.SummaryDifference19%

- Check61 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects a small backend/versioning update and does not change visible study information.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the prior v3.6.2, indicating a minor version update. This update is a software release note and does not affect the study content or visible functionality on the page.SummaryDifference0.0%

- Check89 days agoChange DetectedDifference0.0%

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.